JNJ - Johnson & Johnson logo

JNJ

Johnson & Johnson

Johnson & Johnson develops, manufactures, and sells pharmaceuticals, medical devices, and eye care products, including prescription medication for various diseases and surgical tools for healthcare professionals, with distribution through hospitals and retailers.

⚕️ Healthcare NYSE Listed 1944 $ USD
$1,000 invested 20 years ago →$7,473today

Score Overview

1 Year
Score
Net Growth-21.50%
Net TrendShrank
Net Income Consistency—
Rev Growth2.30%
Rev TrendGrew
Revenue Consistency—
5 Years
Score5.8
Net Growth0.78%
Net Trend40%
Net Income Consistency—
Rev Growth22.38%
Rev TrendEvery year
Revenue Consistency—
10 Years
Score
Net Growth27.21%
Net Trend40%
Net Income Consistency
Rev Growth34.04%
Rev Trend90%
Revenue Consistency
20 Years
Score5.1
Net Growth90.36%
Net Trend50%
Net Income Consistency
Rev Growth80.71%
Rev Trend80%
Revenue Consistency
30 Years
Score
Net Growth7x
Net Trend63%
Net Income Consistency
Rev Growth345.71%
Rev Trend87%
Revenue Consistency
All Time
Score
Net Growth34x
Net Trend68%
Net Income Consistency
Rev Growth15x
Rev Trend90%
Revenue Consistency

Explore the 2021 public Archive ranking →

Where Johnson & Johnson has ranked, year by year

Measure
Fundamentals Window

Showing all available years ranking history by HDB Score.

Reached the top 50 on HDB Score in 1 year, the longest run being 1 in a row — but not in 2021.

  • JNJ

1996: 16.6% · 2021: 9.6% · free through 2021 · longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-09-28
$ 271.95—
1 Year2025-09-26
$ 175.7354.75%
5 Years2021-09-28
$ 141.5892.08%
10 Years2016-09-28
$ 90.96198.99%
20 Years2006-09-28
$ 36.397x
30 Years1996-09-27
$ 12.3322x

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Year
2026$ 96.36B$ 21.04B$ 22.05B
2025$ 94.19B$ 26.80B$ 20.10B
2024$ 88.82B$ 14.06B$ 24.52B
2023$ 85.15B$ 35.15B$ 22.92B
2022$ 79.99B$ 17.94B$ 22.28B
2021$ 78.74B$ 20.87B$ 31.60B
2020$ 82.58B$ 14.71B$ 25.18B
2019$ 82.05B$ 15.11B$ 19.28B
2018$ 81.58B$ 15.29B$ 19.68B
2017$ 76.45B$ 1.30B$ 18.29B
2016$ 71.89B$ 16.54B$ 41.90B
2015$ 70.07B$ 15.40B$ 38.37B
2014$ 74.33B$ 16.32B$ 33.08B
2013$ 71.31B$ 13.83B$ 29.20B
2012$ 67.22B$ 10.85B$ 21.08B
2011$ 65.03B$ 9.67B$ 32.26B
2010$ 61.58B$ 13.33B$ 27.65B
2009$ 61.89B$ 12.26B$ 19.42B
2008$ 63.74B$ 12.94B$ 12.80B
2007$ 61.09B$ 10.57B$ 9.31B
2006$ 53.32B$ 11.05B$ 4.08B
2005$ 50.51B$ 10.06B$ 16.13B
2004$ 47.34B$ 8.18B$ 12.88B
2003$ 41.86B$ 7.19B$ 9.52B
2002$ 36.29B$ 6.59B$ 7.47B
2001$ 32.31B$ 5.66B$ 7.97B
2000$ 29.17B$ 4.95B$ 6.75B
1999$ 28.00B$ 4.27B$ 3.87B
1998$ 23.99B$ 3.00B$ 2.78B
1997$ 22.62B$ 3.30B$ 2.75B
1996$ 21.62B$ 2.88B$ 2.01B
1995$ 18.84B$ 2.40B$ 1.20B
1994$ 15.73B$ 2.00B$ 636M
1993$ 14.13B$ 1.78B$ 372M
1992$ 13.75B$ 1.03B$ 745M
1991$ 12.44B$ 1.46B$ 589M
1990$ 11.23B$ 1.14B$ 826M
1989$ 9.75B$ 1.08B$ 452M
1988$ 9.00B$ 974M$ 660M
1987$ 8.01B$ 833M$ 741M
1986$ 7.00B$ 329M$ 952M
1985$ 6.42B$ 613M$ 735M
JNJ - Johnson & Johnson logo

Johnson & Johnson fundamental performance

Between 2020 and 2025, revenue grew from $ 82.58B to $ 94.19B and net income grew from $ 14.71B to $ 26.80B. Revenue increased in every one of those 5 years; net income in 2.

Across Johnson & Johnson's full reported history, from 1985 to 2025, revenue grew from $ 6.42B to $ 94.19B and net income grew from $ 613M to $ 26.80B. Revenue increased in 90% of the years measured; net income in 68%.

Johnson & Johnson currently holds a 20-year HDB Score of 5.1 out of 10. How the HDB Score is calculated.

Membership

Continue JNJ’s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 3,816 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$99 / year

$149/year · Founding price

Continue with Membership

30-day money-back guarantee.

Explore other companies